Brief: Data From A Long-Term Follow-Up Study To The Olympus Trial Published In The Journal Of Urology

UroGen Pharma

12/02/2025 13:03

Feb 12 (Reuters) - Urogen Pharma  UR8.F :
    * DATA FROM A LONG-TERM FOLLOW-UP STUDY TO THE OLYMPUS TRIAL
THAT
SHOWS A MEDIAN DURATION OF RESPONSE OF NEARLY FOUR YEARS IN
PATIENTS ACHIEVING COMPLETE RESPONSE WITH JELMYTO PUBLISHED IN
THE JOURNAL OF UROLOGY

Source text:  ID:nBw3MmwsWa 
Further company coverage:  UR8.F 

 ((Reuters.Briefs@thomsonreuters.com;))